COMMUNIQUÉS West-GlobeNewswire

Arbutus Reports 2018 Third Quarter Financial Results and Provides Corporate Update

07/11/2018 - 22:01

- AB-506, a second-generation capsid inhibitor, advanced to HBV patient portion of Phase 1a/1b clinical trial - ONPATTRO™ (patisiran) approved by the U.S. Food and Drug Administration (FDA) and the European Medicines [...]

Platelet-Rich Plasma (PRP) Treatments for Hair Loss Now Available at Skin and Laser Surgery Center

07/11/2018 - 19:45

MCLEAN, Va., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Dr. Bajoghli and the Skin and Laser Surgery Center of McLean, Virginia now offer the Platelet-Rich Plasma treatment for patients with thinning hair and/ or hair loss. Hair [...]

Curetis raises €8.9 million through private placements

07/11/2018 - 18:51

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO [...]

DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company

07/11/2018 - 18:31

Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]

DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social

07/11/2018 - 18:31

Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]

Neovacs announces in vivo Proof of Concept success for its IL-4 / IL-13 Kinoid a new Therapeutic Vaccine to treat Mite-induced Asthma

07/11/2018 - 17:46

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE Neovacs announces in vivo Proof of Concept success for its IL-4 / IL-13 Kinoid a new Therapeutic Vaccine to treat Mite-induced Asthma IL-4 / IL-13 Kinoid induces strong [...]

Néovacs : preuve de concept in vivo de son nouveau vaccin thérapeutique dans le traitement de l'asthme

07/11/2018 - 17:46

COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE Néovacs annonce avoir établi la preuve de concept in vivo de son nouveau vaccin thérapeutique IL-4/IL-13 Kinoi de dans le traitement de l'asthme induit [...]

Virtusa Partners with the IBRI to Drive Innovation and Accelerate Therapy Research

07/11/2018 - 17:05

SOUTHBOROUGH, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Virtusa Corporation (NASDAQ GS:VRTU), a global provider of digital strategy, digital engineering, and IT outsourcing services that accelerates business outcomes for [...]

New Eyes Opens Fifth Convenient Las Vegas Location in the Southwest

07/11/2018 - 17:00

New Eyes announces a new location in the southwest region of the Las Vegas Valley, offering a wide range of surgical and medical eye care services such as premier laser cataract surgery, corneal procedures, glaucoma [...]

Konica Minolta Announces New Tools in Exa® Enterprise Imaging Platform to Increase Clinical Productivity and Enhance Communication

07/11/2018 - 16:57

WAYNE, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc. will showcase new features and tools for the Exa Enterprise Imaging platform at RSNA 2018. Exa is a breakthrough solution comprised [...]

SeeThruEquity Initiates .03 Target on HempAmericana (HMPQ)

07/11/2018 - 15:47

NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has [...]

Momenta Pharmaceuticals Announces Publication of Phase 1 Study Data for Anti-FcRn Antibody, M281

07/11/2018 - 15:45

Full data shows safety, tolerability and proof-of-mechanism in healthy volunteers CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) today announced the publication of [...]

Biomerica’s Diagnostic Product Guides Exclusionary Diet Treatment to Successfully Alleviate Symptoms of Ulcerative Colitis (UC) in Prospective Clinical Stud

07/11/2018 - 15:42

Eliminating positive foods identified by Biomerica’s diagnostic product showed statistically significant improvements (p<0.05) in both Quality of Life (FDA Instrument) and disease activity (Mayo Score) in UC patients [...]

ImmuCell to Announce Financial Results for Third Quarter of 2018

07/11/2018 - 15:16

Conference Call Scheduled for Wednesday, November 14, 2018 at 9:00 AM ET PORTLAND, Maine, Nov. 07, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health [...]

Aquinox Pharmaceuticals Announces Third Quarter 2018 Financial Results

07/11/2018 - 15:15

VANCOUVER, British Columbia, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), a pharmaceutical company discovering and developing novel drug candidates to treat inflammation [...]

Obalon Balloon System Data to be Featured in Presentation During 35th ASMBS Annual Meeting at Obesity Week 2018

07/11/2018 - 15:15

Clinical results from over 1,300 patients at 108 sites treated with Obalon’s novel weight loss device solution in commercial use SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a [...]

Akers Biosciences Announces Intention to Explore Strategic Alternatives to Maximize Shareholder Value

07/11/2018 - 15:15

Announces 1:8 Reverse Stock Split THOROFARE, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information [...]

Nemaura Successfully Develops Predictive Algorithms and Alarm Functionality for Continuous Glucose Monitor SugarBEAT®

07/11/2018 - 15:00

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes [...]

K2M Group Holdings, Inc. Stockholders Approve Acquisition by Stryker

07/11/2018 - 15:00

LEESBURG, Va., Nov. 07, 2018 (GLOBE NEWSWIRE) -- At a special meeting today, stockholders of K2M Group Holdings, Inc. (“K2M” or the “Company”) (NASDAQ: KTWO) approved the adoption of the Agreement and Plan of Merger ( [...]